PURPOSE: Mapping the ischaemic penumbra in acute stroke is of considerable clinical interest. For this purpose, mapping tissue hypoxia with (18)F-misonidazole (FMISO) PET is attractive, and is straightforward compared to (15)O PET. Given the current emphasis on penumbra imaging using diffusion/perfusion MR or CT perfusion, investigating the relationships between FMISO uptake and abnormalities with these modalities is important. METHODS: According to a prospective design, three patients (age 54-81 years; admission NIH stroke scale scores 16-22) with an anterior circulation stroke and extensive penumbra on CT- or MR-based perfusion imaging successfully completed FMISO PET, diffusion-weighted imaging and MR angiography 6-26 h after stroke onset, and follow-up FLAIR to map the final infarction. All had persistent proximal occlusion and a poor outcome despite thrombolysis. Significant FMISO trapping was defined voxel-wise relative to ten age-matched controls and mapped onto coregistered maps of the penumbra and irreversibly damaged ischaemic core. RESULTS: FMISO trapping was present in all patients (volume range 18-119 ml) and overlapped mainly with the penumbra but also with the core in each patient. There was a significant (p ≤ 0.001) correlation in the expected direction between FMISO uptake and perfusion, with a sharp FMISO uptake bend around the expected penumbra threshold. CONCLUSION: FMISO uptake had the expected overlap with the penumbra and relationship with local perfusion. However, consistent with recent animal data, our study suggests FMISO trapping may not be specific to the penumbra. If confirmed in larger samples, this preliminary finding would have potential implications for the clinical application of FMISO PET in acute ischaemic stroke.
PURPOSE: Mapping the ischaemic penumbra in acute stroke is of considerable clinical interest. For this purpose, mapping tissue hypoxia with (18)F-misonidazole (FMISO) PET is attractive, and is straightforward compared to (15)O PET. Given the current emphasis on penumbra imaging using diffusion/perfusion MR or CT perfusion, investigating the relationships between FMISO uptake and abnormalities with these modalities is important. METHODS: According to a prospective design, three patients (age 54-81 years; admission NIH stroke scale scores 16-22) with an anterior circulation stroke and extensive penumbra on CT- or MR-based perfusion imaging successfully completed FMISO PET, diffusion-weighted imaging and MR angiography 6-26 h after stroke onset, and follow-up FLAIR to map the final infarction. All had persistent proximal occlusion and a poor outcome despite thrombolysis. Significant FMISO trapping was defined voxel-wise relative to ten age-matched controls and mapped onto coregistered maps of the penumbra and irreversibly damaged ischaemic core. RESULTS: FMISO trapping was present in all patients (volume range 18-119 ml) and overlapped mainly with the penumbra but also with the core in each patient. There was a significant (p ≤ 0.001) correlation in the expected direction between FMISO uptake and perfusion, with a sharp FMISO uptake bend around the expected penumbra threshold. CONCLUSION: FMISO uptake had the expected overlap with the penumbra and relationship with local perfusion. However, consistent with recent animal data, our study suggests FMISO trapping may not be specific to the penumbra. If confirmed in larger samples, this preliminary finding would have potential implications for the clinical application of FMISO PET in acute ischaemic stroke.
Authors: S J Read; T Hirano; D F Abbott; R Markus; J I Sachinidis; H J Tochon-Danguy; J G Chan; G F Egan; A M Scott; C F Bladin; W J McKay; G A Donnan Journal: Ann Neurol Date: 2000-08 Impact factor: 10.422
Authors: W D Heiss; M Huber; G R Fink; K Herholz; U Pietrzyk; R Wagner; K Wienhard Journal: J Cereb Blood Flow Metab Date: 1992-03 Impact factor: 6.200
Authors: R Markus; D C Reutens; S Kazui; S Read; P Wright; B R Chambers; J I Sachinidis; H J Tochon-Danguy; G A Donnan Journal: Stroke Date: 2003-10-16 Impact factor: 7.914
Authors: Philip V Little; Fabian Arnberg; Emma Jussing; Li Lu; Andreas Ingemann Jensen; Nicholas Mitsios; Jan Mulder; Thuy A Tran; Staffan Holmin Journal: J Cereb Blood Flow Metab Date: 2020-05-19 Impact factor: 6.200
Authors: Alexander Seiler; Nicholas P Blockley; Ralf Deichmann; Ulrike Nöth; Oliver C Singer; Michael A Chappell; Johannes C Klein; Marlies Wagner Journal: J Cereb Blood Flow Metab Date: 2017-09-20 Impact factor: 6.200
Authors: Tim D Fryer; Sohail Ejaz; Ulf Jensen-Kondering; David J Williamson; Sergey Sitnikov; Stephen J Sawiak; Franklin I Aigbirhio; Young T Hong; Jean-Claude Baron Journal: PLoS One Date: 2017-11-01 Impact factor: 3.240
Authors: Nicholas R Evans; Jason M Tarkin; John R Buscombe; Hugh S Markus; James H F Rudd; Elizabeth A Warburton Journal: Nat Rev Neurol Date: 2017-10-06 Impact factor: 42.937